Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model

Acta Biomater. 2015 Feb:13:228-44. doi: 10.1016/j.actbio.2014.11.018. Epub 2014 Nov 21.

Abstract

MicroRNA122 (miR122), a liver-specific microRNA, plays critical roles in homeostatic regulation and hepatic-specific differentiation. Induced pluripotent stem cells (iPSCs) have promising potential in regenerative medicine, but it remains unknown whether non-viral vector-mediated miR122 delivery can enhance the differentiation of iPSCs into hepatocyte-like cells (iPSC-Heps) and rescue thioacetamide-induced acute hepatic failure (AHF) in vivo. In this study, we demonstrated that embedment of miR122 complexed with polyurethane-graft-short-branch polyethylenimine copolymer (PU-PEI) in nanostructured amphiphatic carboxymethyl-hexanoyl chitosan (CHC) led to dramatically enhanced miR122 delivery into human dental pulp-derived iPSCs (DP-iPSCs) and facilitated these DP-iPSCs to differentiate into iPSC-Heps (miR122-iPSC-Heps) with mature hepatocyte functions. Microarray and bioinformatics analysis further indicated that CHC/PU-PEI-miR122 promoted the gene-signature pattern of DP-iPSCs to shift into a liver-specific pattern. Furthermore, intrahepatic delivery of miR122-iPSC-Heps, but not miR-Scr-iPSC-Heps, improved liver functions and rescued recipient survival, and CHC-mediated delivery showed a better efficacy than that using phosphate buffered saline as a delivery vehicle. In addition, these transplanted miR122-iPSC-Heps remained viable and could produce circulatory albumin for 4 months. Taken together, our findings demonstrate that non-viral delivery of miR122 shortens the time of iPSC differentiation into hepatocytes and the delivery of miR122-iPSC-Heps using CHC as a vehicle exhibited promising hepatoprotective efficacy in vivo. miR122-iPSC-Heps may represent a feasible cell source and provide an efficient and alternative strategy for hepatic regeneration in AHF.

Keywords: Acute hepatic failure; Induced pluripotent stem cells; Nano structured chitosan; miR122.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation* / drug effects
  • Cell Differentiation* / genetics
  • Chitosan / analogs & derivatives*
  • Chitosan / pharmacology
  • Disease Models, Animal
  • Gene Transfer Techniques*
  • Hepatocytes* / metabolism
  • Hepatocytes* / transplantation
  • Heterografts
  • Humans
  • Induced Pluripotent Stem Cells / metabolism*
  • Liver Failure / genetics
  • Liver Failure / metabolism
  • Liver Failure / pathology
  • Liver Failure / therapy*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • MicroRNAs* / biosynthesis
  • MicroRNAs* / genetics
  • Polyurethanes / pharmacology*

Substances

  • MIRN122 microRNA, human
  • MicroRNAs
  • Polyurethanes
  • carboxymethyl-hexanoyl chitosan
  • Chitosan